[go: up one dir, main page]

ZA921405B - Neuroleptic perhydro-1H-pyrido(1,2-a)pyrazines. - Google Patents

Neuroleptic perhydro-1H-pyrido(1,2-a)pyrazines.

Info

Publication number
ZA921405B
ZA921405B ZA921405A ZA921405A ZA921405B ZA 921405 B ZA921405 B ZA 921405B ZA 921405 A ZA921405 A ZA 921405A ZA 921405 A ZA921405 A ZA 921405A ZA 921405 B ZA921405 B ZA 921405B
Authority
ZA
South Africa
Prior art keywords
alkyl
pyrazines
pyrido
perhydro
neuroleptic
Prior art date
Application number
ZA921405A
Other languages
English (en)
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Thomas Francis Seeger
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA921405B publication Critical patent/ZA921405B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA921405A 1991-02-27 1992-02-26 Neuroleptic perhydro-1H-pyrido(1,2-a)pyrazines. ZA921405B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/661,791 US5157034A (en) 1991-02-27 1991-02-27 Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines

Publications (1)

Publication Number Publication Date
ZA921405B true ZA921405B (en) 1993-08-26

Family

ID=24655130

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921405A ZA921405B (en) 1991-02-27 1992-02-26 Neuroleptic perhydro-1H-pyrido(1,2-a)pyrazines.

Country Status (24)

Country Link
US (1) US5157034A (fr)
EP (1) EP0573467B1 (fr)
JP (1) JP2546770B2 (fr)
KR (1) KR0163413B1 (fr)
AT (1) ATE123284T1 (fr)
AU (1) AU652422B2 (fr)
CA (2) CA2163274C (fr)
DE (2) DE69110135T2 (fr)
DK (1) DK0573467T3 (fr)
ES (1) ES2073914T3 (fr)
FI (3) FI105030B (fr)
HU (1) HU216637B (fr)
IE (1) IE67190B1 (fr)
IL (2) IL112325A (fr)
MX (1) MX9200803A (fr)
MY (1) MY108185A (fr)
NO (1) NO300847B1 (fr)
NZ (1) NZ241739A (fr)
PT (1) PT100160B (fr)
RU (1) RU2090565C1 (fr)
TW (1) TW207540B (fr)
WO (1) WO1992015580A1 (fr)
YU (1) YU48311B (fr)
ZA (1) ZA921405B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725736B2 (ja) * 1991-02-27 1995-03-22 ファイザー・インコーポレーテッド トランス−ピペリジン−2,5−ジカルボキシレートの製法
ATE185565T1 (de) * 1992-06-16 1999-10-15 Pfizer Verfahren und zwischenprodukte zur herstellung von bis-aza-bicyclischen anxiolytica
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
NZ290936A (en) * 1994-09-30 1998-01-26 Pfizer 2,7-substituted octahydro-1h-pyrido[1,2-a]pyrazine derivatives
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
DE19960204A1 (de) * 1999-12-14 2001-06-28 Aventis Pharma Gmbh Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP1608648B1 (fr) * 2003-03-12 2012-07-18 Pfizer Products Inc. Derives azabicycliques de pyridyloxymethyl et de benzisoxazole
HRP20160180T1 (hr) 2003-04-24 2016-03-25 Incyte Holdings Corp Derivati aza spiro alkana kao inhibitori metaloproteaza
WO2007143600A2 (fr) * 2006-06-05 2007-12-13 Incyte Corporation Inhibiteurs de la sheddase combinés avec des substances immunothérapeutiques se liant à cd30 destinés au traitement de maladies associées à cd30
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681938A (en) * 1984-08-27 1987-07-21 Ciba-Geigy Corporation Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compositions for treating tuberculosis
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
WO1990008148A1 (fr) * 1989-01-23 1990-07-26 Pfizer Inc. Agents anxiolytiques bis-aza-bicycliques

Also Published As

Publication number Publication date
AU652422B2 (en) 1994-08-25
IE67190B1 (en) 1996-03-06
IE920601A1 (en) 1992-09-09
DE69110135T2 (de) 1995-10-19
CA2101518C (fr) 1997-11-25
CA2163274C (fr) 1999-02-09
NO933049L (no) 1993-08-26
NO933049D0 (no) 1993-08-26
FI20030361L (fi) 2003-03-11
FI933753A0 (fi) 1993-08-26
CA2101518A1 (fr) 1992-08-28
CA2163274A1 (fr) 1992-08-28
EP0573467B1 (fr) 1995-05-31
YU19892A (sh) 1994-11-15
ATE123284T1 (de) 1995-06-15
US5157034A (en) 1992-10-20
PT100160B (pt) 1999-09-30
FI105030B (fi) 2000-05-31
PT100160A (pt) 1993-05-31
HUT66965A (en) 1995-01-30
TW207540B (fr) 1993-06-11
EP0573467A1 (fr) 1993-12-15
IL112325A (en) 1997-08-14
FI112865B (fi) 2004-01-30
NO300847B1 (no) 1997-08-04
FI114214B (fi) 2004-09-15
HU216637B (hu) 1999-07-28
MY108185A (en) 1996-08-30
HU9302427D0 (en) 1993-11-29
JP2546770B2 (ja) 1996-10-23
DK0573467T3 (da) 1995-10-09
IL101021A (en) 1996-03-31
YU48311B (sh) 1998-05-15
KR930703315A (ko) 1993-11-29
FI933753L (fi) 1993-08-26
IL112325A0 (en) 1995-03-30
AU1259992A (en) 1992-10-06
DE9190206U1 (de) 1993-10-14
JPH06500120A (ja) 1994-01-06
RU2090565C1 (ru) 1997-09-20
MX9200803A (es) 1992-08-31
WO1992015580A1 (fr) 1992-09-17
ES2073914T3 (es) 1995-08-16
KR0163413B1 (ko) 1998-12-01
FI20000354L (fi) 2000-02-17
NZ241739A (en) 1994-07-26
DE69110135D1 (de) 1995-07-06

Similar Documents

Publication Publication Date Title
ZA921405B (en) Neuroleptic perhydro-1H-pyrido(1,2-a)pyrazines.
DK0478954T3 (da) Serotonin 5HT1A- og 5HT1D-antagonister
DK0546583T3 (da) Piperidinyl- og piperazinylcyclohexanoler
ATE130850T1 (de) Fulgimidderivate.
GR3026231T3 (en) 3-aminopiperidine derivatives and related nitrogen containing heterocycles.
DK0526068T3 (da) Phthalocyaninpigmentsammensætninger
HU9201145D0 (en) New benzimidazole derivatives
FI922561A0 (fi) Derivat av 1-metylkarbapenem, deras framstaellning och anvaendning som antibiotika.
DE69025230D1 (de) 2,5-Diaryl-tetrahydrofurane und deren Analoge als PAF-Antagonisten
MX9203360A (es) Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen.
ES2083501T3 (es) Sintesis de 2-aril-5-(fluormetil)pirroles utiles como agentes pesticidas y como compuestos intermedios para la preparacion de dichos agentes.
RU93045711A (ru) Нейролептические пергидро-1h-пиридо(1,2-a)пиразины, способ их получения, фармацевтическая композиция, способ лечения
NZ241659A (en) 4-pyrimidinone derivatives and pharmaceutical compositions
ATE103316T1 (de) Tintenzusammensetzungen auf waesseriger basis.
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
DK0445013T3 (da) N-Cycloalkylalkylaminer, fremgangsmåde til fremstilling deraf, deres anvendelse som lægemiddel og deres syntese-mellemprodukter
FI810618L (fi) Nya kefalosporiner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
DE3684133D1 (de) Oximester von stubstituierten chinolin-8-carbonsaeuren und deren verwendung als herbizide.
FI77022B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrrolaettiksyraderivat.
IL66692A0 (en) 6alpha-methoxy-penicillins and salts thereof,their preparation and pharmaceutical compositions containing them
CA2177392A1 (fr) Composes tricycliques pouvant inhiber les tyrosines kinases de la famille des recepteurs du facteur de croissance epidermique
ES2115178T3 (es) Derivados de indanotrionas y de hidrazidas y su aplicacion terapeutica.
ES8900014A1 (es) Un procedimiento para la preparacion de derivados del acido 1-(fenil-sustituido)-4-carboxi-naftalen-2-carboxilico.